Study Finds 60% of DSM-5-TR Panel Members Had Undisclosed Financial Ties to Pharmaceutical Industry
Objective To assess the extent and types of financial ties to industry of panel and task force members of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders…
Read the full articleYou might also wanna read
Financial Conflicts of Interest of US-Based Authors in Neurology Journals: Cross-Sectional Study Using the Open Payments Database
Jade Smith of Dartmouth College discusses financial conflicts of interest of authors published in high-impact neurology journals. Show refer
Medical Device Industry Payments to Healthcare Professionals and Organizations in Japan: An Evaluation of Scale, Distribution, and Transparency Practices, 2019-2022
Background Financial relationships between the medical device industry and healthcare providers have raised concerns about conflicts of inte
Walberg, Allen Crack Down on Billing Abuse in Autism Therapy Industry
Education and Workforce Committee Chairman Tim Walberg (R-MI) and Health, Employment, Labor, and Pensions Subcommittee Chairman Rick W. Alle
FDA Panel on Peptide Drugs Includes Experts with Financial Ties to Unproven Chemical Industry
Several popular peptide injections have been praised by Health Secretary Robert F. Kennedy Jr.
medpagetoday.com·17d ago
Financial Disclosure: Dr. Anita H. Clayton's Industry Relationships
There is an evolution going on in depression -- be a part of it!
mdsc.pe·17d ago
Payment Trends for Neurologist-Prescribed Drugs in Medicare Part D
Dr. Adam de Havenon discusses the Neurology Journal article, "Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part
Comments
Sign in to join the conversation.
No comments yet. Be the first.